Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2020-08-31 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text content. The true document length is only 281 characters, which is very short and contains no financial data, report content, or announcements. It does not contain any report, announcement, or regulatory filing information. Given the lack of content and the presence of only images, this document cannot be classified as a report or announcement type. According to the rules, such minimal content with no text is best classified as Regulatory Filings (RNS) as a fallback category.
2020-08-31 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that subsequent to the declaration of unaudited ....
Regulatory Filings Classification · 95% confidence The document is an intimation to stock exchanges about a scheduled conference call following the declaration of unaudited standalone and consolidated financial results for the quarter ended June 30, 2020 (Q1 FY21). It includes details about the conference call for investors and analysts, including date, time, participants, and dial-in numbers. The document does not contain the financial results themselves, nor detailed financial statements or analysis, but rather announces the event where such results will be discussed. This matches the definition of a Call Transcript (CT) document type, as it relates to a conference call about quarterly results. However, since this is an announcement of the conference call and not the transcript itself, it is more accurately classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the call, not the transcript or the financial report itself. The document length (13,367 characters) is sufficient for a detailed announcement but does not contain the actual transcript or financial data. Therefore, the best classification is Regulatory Filings (RNS).
2020-08-31 English
Loss of Share Certificates
Regulatory Filings
2020-08-29 English
Morepen Laboratories Ltd has informed BSE regarding loss of share Certificates of the Company
Regulatory Filings Classification · 95% confidence The document is a series of letters addressed to stock exchanges (National Stock Exchange of India Ltd. and Bombay Stock Exchange Limited) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting such events. The content is administrative and regulatory in nature, notifying the exchanges about lost share certificates and related shareholder information. There is no financial data, earnings information, management discussion, or report publication. The document is not a report itself but a regulatory notification about share certificate loss. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-08-29 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (National Stock Exchange of India Ltd. and Bombay Stock Exchange Limited) regarding the loss of share certificates and the issuance of duplicate share certificates. It references Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and duplicate issuance. The content includes detailed information about shareholders who reported lost certificates and the issuance of duplicates, but it does not contain financial statements, earnings data, management discussion, or any report-type content. It is a regulatory announcement informing the exchanges and public about share certificate status changes. This fits best under Regulatory Filings (RNS), as it is a compliance-related disclosure that does not fit into other specific categories like capital changes or director dealings.
2020-08-26 English
Morepen Laboratories Ltd has informed BSE regarding loss of share Certificates and issue of duplicate share certificates by the Company
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (National Stock Exchange of India Ltd. and Bombay Stock Exchange Limited) regarding the loss of share certificates and the issuance of duplicate share certificates. It references Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and replacement procedures. The content includes detailed information about shareholders who have lost share certificates and the issuance of duplicates, including folio numbers, certificate numbers, and distinctive numbers. There is no financial data, earnings information, management discussion, or report publication mentioned. The document is an official notification about share certificate status and related administrative actions, which fits the category of a Regulatory Filing (RNS) as it is a regulatory compliance communication and does not fit into more specific categories like share issue or capital change (SHA) or director dealings (DIRS).
2020-08-26 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.